ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

PAK3 promotes the metastasis of hepatocellular carcinoma by regulating EMT process

Gao, Zhi; Zhong, Mengya; Ye, Zhijian; Wu, Zhengxin; Xiong, Yubo; Ma, Jinsong; Chen, Huiyu; Zhu, Yuekun; Yang, Yan; Zhao, Yongxiang*; Zhang, Zhiyong*广西大学; 哈尔滨医科大学; 厦门大学; 1; i
American Journal of Cancer Research2022DOI: 10.7150/jca.61918
8被引10阅读
引用收藏
分享

摘要

Purpose: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. The malignant biological behavior of HCC is closely related to epithelial-mesenchymal transition (EMT), and EMT plays an important role in the progression, migration and metastasis of HCC. P21-activated kinase 3 (PAK3) is a serine/threonine protein kinase, and PAK3 affects the EMT, proliferation, metastasis and invasion of HCC. Methods: In this study, the relationship between PAK3 and HCC was first analyzed by bioinformatics, and then, the expression of PAK3 in clinical samples was detected by immunohistochemistry (IHC), quantitative real-time PCR (qRT-PCR) and Western blotting. Subsequently, the expression of PAK3 was further confirmed in HCC cells. In addition, after the overexpression or knockdown of PAK3 in cells, the proliferation, migration and invasion abilities of these cells were assessed by Cell Counting Kit-8 (CCK-8), wound healing and Transwell assays, and the results were confirmed in vivo experiments in mice. In addition, we also verified that PAK3 affected the EMT and EMT-related pathway of HCC through qRT-PCR, Western blotting and immunofluorescence experiments. Results: Through database analysis, we found that PAK3 was highly expressed in HCC patients and was positively correlated with tumor stage and grade, suggesting that PAK3 expression was closely related to HCC occurrence and development. We subsequently confirmed that PAK3 was overexpressed in HCC clinical samples and HCC cell lines and that PAK3 promoted the proliferation, migration and invasion of HCC cells in vitro. Finally, we found that PAK3 regulated EMT-related molecule expression and EMT-related TGF-beta/smad signaling pathway. Conclusion: High expression of PAK3 enhances the invasion of HCC and regulates EMT, suggesting that PAK3 may be a potential target for the treatment of HCC.

学科与关键词

关键词
PAK3HCCEMTsmad
相关
加载中…
  • Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma
    Xu, Weikang; Lu, Xinyu; Liu, Jing; Chen, Qianhui; Huang, Xuan; Huang, Kuiyuan; Liu, Hongyan*; Zhu, Wei*; Zhang, Xiaoyong*Frontiers in Oncology, 2021, 11.被引 4
  • MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4)
    Xue Jing; Chen Li Zhang*; Li Zhan Zhan; Hu Ying yun; Yan Shi peng; Liu Li YaMolecular and Cellular Biochemistry, 2015, 399(1-2): 77-86.
  • MST4 negatively regulates the EMT, invasion and metastasis of HCC cells by inactivating PI3K/AKT/Snail1 axis
    Dian, Mei-Juan; Li, Jing; Zhang, Xiao-Ling; Li, Zi-Jian; Zhou, Ying; Zhou, Wei; Zhong, Qiu-Ling; Pang, Wen-Qian; Lin, Xiao-Lin; Liu, Tao; Liu, Yi-An; Li, Yong-Long; Han, Liu-Xin; Zhao, Wen-Tao; Jia, Jun-Shuang; Xiao, Sheng-Jun; Xiao, Dong*; Xia, Jia-Wei*; Hao, Wei-Chao*American Journal of Cancer Research, 2021, 12(15): 4463-4477.被引 16
查看全部 →

发表信息

论文状态
公开发表
期刊
American Journal of Cancer Research
发表日期
2022
卷期
第 13 卷, 第 1 期
页码
153-161
DOI
10.7150/jca.61918
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82073373]; Natural Science Foundation of Guangxi Province of China [{2015}57]; National 10,000-person Program for Leading Talents in Scientific and Technological Innovation, "Hundred talents plan" for colleges and universities in Guangxi to introduce overseas high-level talents; Scientific and Technological Innovation Major Base of Guangxi [2018-15-Z04]; State Project for Essential Drug Research and Development [2019ZX09301132]; Guangxi Key Research and Development Project [AB20117001]; Guangxi science and technology bases and talent special project [AD17129062]

作者

  • G

    Gao, Zhi (第一作者)

    guangxi med univ · i

  • Z

    Zhong, Mengya

    xiamen univ

查看全部 11 位作者收起作者
  • Y

    Ye, Zhijian

    xiamen univ · guangxi med univ · i

  • W

    Wu, Zhengxin

    guangxi univ

  • X

    Xiong, Yubo

    xiamen univ

  • M

    Ma, Jinsong

    xiamen univ

  • C

    Chen, Huiyu

    xiamen univ

  • Z

    Zhu, Yuekun

    1 · harbin med univ

  • Y

    Yang, Yan

    xiamen univ

  • Z

    Zhao, Yongxiang (通讯)

    guangxi med univ · i

  • Z

    Zhang, Zhiyong (通讯)

    guangxi med univ · i · new · rutgers

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417